Plain-English translation of NCT07059637 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new model of care called a sarcopenia clinic—a team-based approach specifically designed to diagnose and treat muscle loss that commonly occurs in people with COPD. Researchers will compare this specialized clinic to standard COPD clinics to see if the personalized, multidisciplinary approach helps patients do better over time.
Many people with COPD lose muscle mass, which makes breathing harder and increases the risk of hospitalization and poor outcomes. This trial was designed because doctors need to know if a specialized team approach focused on muscle loss can help COPD patients recover better and stay healthier.
You likely qualify if…
You likely don't qualify if…
After being hospitalized for a COPD flare-up, you will be randomly assigned to either the new sarcopenia clinic or a standard COPD clinic for follow-up care. Over the next year, you will have regular appointments where doctors and specialists will assess your muscle mass, breathing, and overall health. The study team will track your progress and compare how well patients do in each type of clinic.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States
The Cleveland Clinic
Enrollment target
~80 participants
Started
October 2025
Primary completion
October 2027
Age range
40 Years and older
Last updated on clinicaltrials.gov in October 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Amy Attaway, MD
The Cleveland Clinic
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.